Ultralife (ULBI) Liabilities and Shareholders Equity (2010 - 2026)

Ultralife's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $220.6 million for Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 1.39% year-over-year to $220.6 million in Q1 2026; TTM through Mar 2026 was $880.8 million, a 11.99% increase from a year earlier, with the FY2025 full-year figure at $216.9 million, down 1.61% from the prior year.
• Liabilities and Shareholders Equity advanced to $220.6 million in Q1 2026 per ULBI's latest filing, from $216.9 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $223.8 million in Q1 2025 and bottomed at $161.4 million in Q1 2022.
• The 5-year median for Liabilities and Shareholders Equity is $176.1 million (2023), against an average of $188.7 million.
• Across the five-year window, Liabilities and Shareholders Equity dropped 3.18% in 2024 and soared 30.12% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $168.4 million in 2022, then increased by 5.85% to $178.3 million in 2023, then climbed by 23.66% to $220.5 million in 2024, then dropped by 1.61% to $216.9 million in 2025, then rose by 1.71% to $220.6 million in 2026.
• Per Business Quant, the three latest ULBI Liabilities and Shareholders Equity figures stand at $220.6 million (Q1 2026), $216.9 million (Q4 2025), and $222.2 million (Q3 2025).